Westwood Holdings Group Inc. Boosts Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Westwood Holdings Group Inc. lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 6.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 253,745 shares of the medical device company's stock after acquiring an additional 14,319 shares during the quarter. Westwood Holdings Group Inc. owned about 0.13% of Cooper Companies worth $23,327,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD grew its stake in Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock worth $324,466,000 after buying an additional 2,957,421 shares during the last quarter. Norges Bank acquired a new stake in Cooper Companies in the fourth quarter worth $217,906,000. FMR LLC raised its holdings in Cooper Companies by 97.6% in the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after purchasing an additional 1,095,805 shares during the period. Raymond James Financial Inc. bought a new stake in shares of Cooper Companies during the fourth quarter worth $64,826,000. Finally, Victory Capital Management Inc. increased its position in shares of Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after acquiring an additional 574,899 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Performance

Shares of Cooper Companies stock traded down $0.07 during trading on Thursday, hitting $79.30. 2,037,369 shares of the company's stock traded hands, compared to its average volume of 1,486,717. The Cooper Companies, Inc. has a 1 year low of $69.81 and a 1 year high of $112.38. The business has a 50-day simple moving average of $80.28 and a 200-day simple moving average of $89.52. The stock has a market capitalization of $15.86 billion, a P/E ratio of 40.67, a PEG ratio of 2.25 and a beta of 1.08. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. As a group, analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of analyst reports. Wall Street Zen raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a research report on Wednesday. Piper Sandler restated an "overweight" rating and issued a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. JPMorgan Chase & Co. lowered their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Finally, Robert W. Baird reduced their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.